# Host Response to Infection and Treatment in Filarial Diseases

> **NCT00001230** · — · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 500 (estimated)

## Conditions studied

- Filariasis
- Helminthiasis
- Parasitic Infection
- Mansonelliasis
- Onchocerciasis

## Interventions

- **DRUG:** Diethylcarbamazine

## Key facts

- **NCT ID:** NCT00001230
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 1991-03-15
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001230, "Host Response to Infection and Treatment in Filarial Diseases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00001230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*